Tech Company Financing Transactions
Clinical Ink Funding Round
Clayton Associates and private investors invested in a $4.3 million Series B funding round for Clinical Ink. The round closed on 10/18/2013.
Transaction Overview
Company Name
Announced On
10/18/2013
Transaction Type
Venture Equity
Amount
$4,300,000
Round
Series B
Investors
Clayton Associates (Lead Investor) (Matthew King)
Proceeds Purpose
This infusion of funds will allow Clinical Ink to aggressively build the capabilities needed to address the rapidly increasing customer demand for eSource technology in clinical trials.
Company Information
Company Status
Private & Independent
Industry
Software
Mailing Address
110 Gibraltar Rd. 150
Horsham, PA 19044
USA
Horsham, PA 19044
USA
Phone
Website
Email Address
Overview
Purpose-built to capture data electronically at the point of care, SureSource dramatically reduces development costs and timelines from Start to Submit.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ed Seguine
Chief Financial Officer
Scott Miltenberger
Chief Operating Officer
Jonathan Andrus
President
Doug Pierce
Browse more venture capital transactions:
Prev: 10/18/2013: Cormatrix Cardiovascular venture capital transaction
Next: 10/18/2013: Biodesy venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document every notable VC transaction. VC investment data records reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs